0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editor's Correspondence |

Thiazolidinediones and the Risk of Nontraumatic Fractures in Patients With Diabetes: In Reply

Elsa S. Strotmeyer, PhD, MPH; Ann V. Schwartz, PhD; Anne B. Newman, MD, MPH
Arch Intern Med. 2006;166(9):1043. doi:10.1001/archinte.166.9.1043.
Text Size: A A A
Published online

Extract

In their letter published in the January 9, 2006, issue of the ARCHIVES, Mascitelli and Pezzetta1 state that thiazolidinedione use has been shown to decrease hip and femoral neck bone mineral density (BMD)2 and suggest that this is an explanation for our report that adults with type 2 diabetes mellitus are at higher fracture risk compared with adults without diabetes in the Health, Aging, and Body Composition (Health ABC) Study.3 While we agree that thiazolidinedione use may be associated with bone loss, the prevalence of thiazolidinedione use was too low to account for the increased fracture risk associated with type 2 diabetes mellitus that we reported.3 The reference that Mascitelli and Pezzetta1 cite is also from the Health ABC Study,2 and only 11 (2%) of 566 participants with diabetes in our report used a thiazolidinedione at the start of the study in 1997-1998. In the first 4 years of the study during which our fracture outcomes were collected, only 69 (12%) of 566 participants with diabetes used a thiazolidinedione.4 Our analyses of diabetes and fracture risk considered baseline BMD to adjust for differences among thiazolidinedione users.3 In addition, although not included our report, we found a similar prevalence of thiazolidinedione use among participants with diabetes who did and did not experience a fracture. In a recently published abstract,4 we noted that there were modest losses in total hip BMD associated with longer duration of thiazolidinedione use during the first 4 years of the study, although it is an unlikely explanation for our findings given the low prevalence of thiazolidinedione users over this time. Furthermore, several cohort studies conducted prior to the introduction of thiazolidinedione use have found an association between type 2 diabetes mellitus and incident fracture risk,5,6 suggesting that other aspects of diabetes are risk factors for fracture. As more participants with diabetes are exposed to thiazolidinedione use over time, it may be possible to determine if there is a specific effect on fracture that is independent of diabetes.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 1

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles
Jobs
JAMAevidence.com
brightcove.createExperiences();